stockrowSTERIS plc
STE Healthcare Medical Devices
STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.
- Revenue
- +8.79%
- EPS
- +12.8%
- Free cash flow
- +43.6%
- Total debt
- −0.21%
Quarter to September 2026, against a year earlier
Follow STE
Alert me
STERIS plc (STE) Revenue growth
STERIS plc's revenue growth over the twelve months to 30 September 2026 was 8.12%, down 0.6 percentage points from fiscal 2026 (8.73%). Over the past ten years it has ranged from 0.28% (fiscal 2018) to 35.9% (fiscal 2022); the current reading is higher than 50% of that period. That is below the Medical Devices industry median of 10.4% and in line with the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 8.73% | 2.49 |
| FY2025 | 6.24% | (7.04) |
| FY2024 | 13.3% | 5.87 |
| FY2023 | 7.41% | (28.50) |
| FY2022 | 35.9% | 33.38 |
| FY2021 | 2.53% | (6.41) |
| FY2020 | 8.94% | 2.75 |
| FY2019 | 6.19% | 5.91 |
| FY2018 | 0.28% | (16.43) |
| FY2017 | 16.7% | (4.29) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 8.79% | 1.49 |
| Jun 2026 | 7.30% | 0.02 |
| Mar 2026 | 7.28% | (1.88) |
| Dec 2025 | 9.16% | (0.73) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| GKOS Glaukos Corporation compare | 46.9% |
| PEN Penumbra, Inc. compare | 17.0% |
| GMED Globus Medical, Inc. compare | 13.4% |
| DXCM DexCom, Inc. compare | 13.0% |
| STE STERIS plc | 8.12% |
| PHG Koninklijke Philips N.V. compare | 7.98% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 6.98% |
| GEHC GE HealthCare Technologies Inc. compare | 6.87% |
| SNN Smith & Nephew SNATS, Inc. compare | 4.81% |
| Medical Devices industry median | 10.4% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on STE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement